Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1237, doi. 10.3390/pharmaceutics16091237
- By:
- Publication type:
- Article
Works by Ovcharenko, Dmitriy
Results: 7
1
2
Effective Delivery of Functional siRNAs into Cells.
- Published in:
- Pharmaceutical Discovery, 2005, v. 5, p. 21
- By:
- Publication type:
- Article
3
MicroRNAs control transcription factor NF-kB (p65) expression in human ovarian cells.
- Published in:
- Functional & Integrative Genomics, 2015, v. 15, n. 3, p. 271, doi. 10.1007/s10142-014-0413-0
- By:
- Publication type:
- Article
4
Protein kinases controlling PCNA and p53 expression in human ovarian cells.
- Published in:
- Functional & Integrative Genomics, 2009, v. 9, n. 2, p. 185, doi. 10.1007/s10142-008-0102-y
- By:
- Publication type:
- Article
5
Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.
- Published in:
- Cancer Biology & Therapy, 2019, v. 20, n. 9, p. 1281, doi. 10.1080/15384047.2019.1632131
- By:
- Publication type:
- Article
6
Identification of MicroRNAs controlling human ovarian cell proliferation and apoptosis.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 1, p. 49, doi. 10.1002/jcp.21999
- By:
- Publication type:
- Article
7
Identification of MicroRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen.
- Published in:
- Journal of Cellular Physiology, 2009, v. 219, n. 2, p. 415, doi. 10.1002/jcp.21689
- By:
- Publication type:
- Article